Detalhe da pesquisa
1.
PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction.
Int J Mol Sci
; 24(11)2023 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37298640
2.
Complicated etiology may influence correlation between portal pressure gradient and fibrosis staging.
Gastrointest Endosc
; 96(2): 387, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35843675
3.
EUS-guided portal pressure gradient measurement: a promising tool in noncirrhotic portal hypertension.
Gastrointest Endosc
; 93(1): 287, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33353640
4.
Inflammation activity affects liver stiffness measurement by magnetic resonance elastography in MASLD.
Dig Liver Dis
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38744558
5.
SAMM50-rs2073082, -rs738491 and -rs3761472 Interactions Enhancement of Susceptibility to Non-Alcoholic Fatty Liver Disease.
Biomedicines
; 11(9)2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760857
6.
Spleen stiffness determined by spleen-dedicated device accurately predicted esophageal varices in cirrhosis patients.
Ther Adv Chronic Dis
; 14: 20406223231206223, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37928628
7.
MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population.
Front Endocrinol (Lausanne)
; 14: 1199429, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37424875
8.
Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice.
Front Immunol
; 13: 974872, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36466835
9.
Letter: NSBB for fatty liver disease-Still a long way to go.
Aliment Pharmacol Ther
; 58(8): 847, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768286